Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.2700
-0.0100 (-3.57%)
Jul 25, 2025, 4:10 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 59.30 million as of July 25, 2025. Its market cap has decreased by -85.06% in one year.
Market Cap
59.30M
Enterprise Value
41.31M
Revenue
-1.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 59.30M, an increase of 703.61%. That is a compound annual growth rate of 9.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 59.30M | -78.45% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | 474.09M | 234.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 128.56B |
| Pro Medicus | 33.84B |
| Cochlear | 20.35B |
| Sonic Healthcare | 13.82B |
| Ramsay Health Care | 8.98B |
| Telix Pharmaceuticals | 7.21B |
| Ansell | 4.45B |
| Mesoblast | 3.06B |